 MindMed MNMD stock is getting a buzz today thanks to approval from the FDA to move forward with a clinical trial of MM-120. The post MNMD Stock: The FDA Go-Ahead That Has MindMed Investors Feeling Euphoric Today appeared first on InvestorPlace. 